AUXILIUM PHARMACEUTICALS INC 4
4 · AUXILIUM PHARMACEUTICALS INC · Filed Jan 30, 2015
Insider Transaction Report
Form 4
JOBES ELIZABETH VARKI
Chief Compliance Officer
Transactions
- Other
Nonqualified Employee Stock Option (Right to Buy)
2015-01-29$36.53/sh−20,000$730,600→ 0 totalExercise: $17.68From: 2013-05-07Exp: 2022-05-07→ Common Stock (20,000 underlying) - Other
Common Stock
2015-01-29$36.53/sh−13,767$502,909→ 0 total - Other
Nonqualified Employee Stock Option (Right to Buy)
2015-01-29$36.53/sh−11,250$410,963→ 0 totalExercise: $18.30From: 2014-02-07Exp: 2023-02-07→ Common Stock (11,250 underlying) - Other
Nonqualified Employee Stock Option (Right to Buy)
2015-01-29$36.53/sh−13,700$500,461→ 0 totalExercise: $28.30From: 2015-02-18Exp: 2024-02-17→ Common Stock (13,700 underlying)
Footnotes (2)
- [F1]In accordance with the provisions of the Amended and Restated Agreement and Plan of Merger, dated as of November 17, 2014 (the "Merger Agreement"), among Auxilium Pharmaceuticals, Inc., Endo International plc, Endo U.S. Inc., and Avalon Merger Sub Inc., as of the effective time of the closing of the merger on January 29, 2015, these restricted stock units and unvested shares of restricted stock were cancelled in exchange for a cash payment determined pursuant to the Merger Agreement.
- [F2]In accordance with the provisions of the Amended and Restated Agreement and Plan of Merger, dated as of November 17, 2014 (the "Merger Agreement"), among Auxilium Pharmaceuticals, Inc., Endo International plc, Endo U.S. Inc., and Avalon Merger Sub Inc., as of the effective time of the closing of the merger on January 29, 2015, these options were cancelled in exchange for a cash payment determined pursuant to the Merger Agreement.